AADI

Aadi Bioscience, Inc.

1.84 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Aadi Bioscience, Inc. stock is down -1.08% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 85.71% of the previous 6 May’s closed higher than April. 0% of analysts rate it a buy.

About Aadi Bioscience, Inc.

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin.